Blog Category

Strategy

Biophytis appoints Yann Meunier and Bernard Lévy to its Scientific Advisory Board

,

/

27 November 2023

Biophytis provides an update on its early access programs for Sarconeos (BIO101) in the treatment of severe forms of COVID-19

,

/

19 September 2023

Biophytis Strengthens its Management Team with the Appointment of its Chief Business Officer

,

/

14 September 2023

Biophytis announces next regulatory steps in Europe and the United States for its COVA project

,

/

16 August 2023

Biophytis strengthens its management team

,

/

2 May 2023

Biophytis to meet with FDA to advance Sarconeos (BIO101) development in Sarcopenia from Phase 2 to Phase 3

,

/

16 December 2021

Biophytis announces US centers to restart recruitment for the COVA phase 2-3 study with Sarconeos (BIO101) in COVID-19

,

/

15 November 2021

Biophytis leadership is reinforced with new Chief Medical Officer appointment

,

/

9 September 2021

Judgment rendered on July 16, 2021 in the proceedings between Biophytis and Negma Group Ltd by the Execution Judge from the Paris Court of Justice

, , ,

/

20 July 2021

Biophytis Reinforces Leadership Teams with Three Senior Appointments

, , ,

/

8 July 2021

Upcoming Potential Value Generating Milestones

,

/

3 December 2020

Biophytis has appointed Evelyne Nguyen as CFO and Strengthens Senior Management Team

,

/

2 January 2020